Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia

V. Praphanphoj, Simeon Boyd, L. J. Waber, S. W. Brusilow, M. T. Geraghty

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Intravenous sodium benzoate and sodium phenylacetate have been used successfully in the treatment of acute hyperammonaemia in patients with urea cycle disorders. They provide alternative pathways for waste nitrogen disposal and help maintain nitrogen homeostasis. However, we report three patients with hyperammonaemia who received inappropriate doses of intravenous sodium benzoate and sodium phenylacetate that resulted in severe complications. Ambiguous medical prescriptions and inadequate cross-checking of drug dosage by physicians, nurses and pharmacists were the main causes of these incidents. All the patients presented with alteration in mental status, Kussmaul respiration and a partially compensated metabolic acidosis with an increased anion gap. Two patients developed cerebral oedema and hypotension and died. The third survived after haemodialysis. Plasma levels of benzoate and phenylacetate were excessively high. The possible mechanisms of toxicity, management and safety measures are discussed.

Original languageEnglish (US)
Pages (from-to)129-136
Number of pages8
JournalJournal of Inherited Metabolic Disease
Volume23
Issue number2
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Sodium Benzoate
Hyperammonemia
Nitrogen
Inborn Urea Cycle Disorder
Safety Management
Acid-Base Equilibrium
Benzoates
Brain Edema
Therapeutics
Acidosis
Pharmacists
Hypotension
Prescriptions
Renal Dialysis
Respiration
Homeostasis
Nurses
Physicians
phenylacetic acid
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics
  • Endocrinology

Cite this

Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia. / Praphanphoj, V.; Boyd, Simeon; Waber, L. J.; Brusilow, S. W.; Geraghty, M. T.

In: Journal of Inherited Metabolic Disease, Vol. 23, No. 2, 2000, p. 129-136.

Research output: Contribution to journalArticle

@article{8ea8ae8bc2dd4cfc8096352b7c791666,
title = "Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia",
abstract = "Intravenous sodium benzoate and sodium phenylacetate have been used successfully in the treatment of acute hyperammonaemia in patients with urea cycle disorders. They provide alternative pathways for waste nitrogen disposal and help maintain nitrogen homeostasis. However, we report three patients with hyperammonaemia who received inappropriate doses of intravenous sodium benzoate and sodium phenylacetate that resulted in severe complications. Ambiguous medical prescriptions and inadequate cross-checking of drug dosage by physicians, nurses and pharmacists were the main causes of these incidents. All the patients presented with alteration in mental status, Kussmaul respiration and a partially compensated metabolic acidosis with an increased anion gap. Two patients developed cerebral oedema and hypotension and died. The third survived after haemodialysis. Plasma levels of benzoate and phenylacetate were excessively high. The possible mechanisms of toxicity, management and safety measures are discussed.",
author = "V. Praphanphoj and Simeon Boyd and Waber, {L. J.} and Brusilow, {S. W.} and Geraghty, {M. T.}",
year = "2000",
doi = "10.1023/A:1005661631281",
language = "English (US)",
volume = "23",
pages = "129--136",
journal = "Journal of Inherited Metabolic Disease",
issn = "0141-8955",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia

AU - Praphanphoj, V.

AU - Boyd, Simeon

AU - Waber, L. J.

AU - Brusilow, S. W.

AU - Geraghty, M. T.

PY - 2000

Y1 - 2000

N2 - Intravenous sodium benzoate and sodium phenylacetate have been used successfully in the treatment of acute hyperammonaemia in patients with urea cycle disorders. They provide alternative pathways for waste nitrogen disposal and help maintain nitrogen homeostasis. However, we report three patients with hyperammonaemia who received inappropriate doses of intravenous sodium benzoate and sodium phenylacetate that resulted in severe complications. Ambiguous medical prescriptions and inadequate cross-checking of drug dosage by physicians, nurses and pharmacists were the main causes of these incidents. All the patients presented with alteration in mental status, Kussmaul respiration and a partially compensated metabolic acidosis with an increased anion gap. Two patients developed cerebral oedema and hypotension and died. The third survived after haemodialysis. Plasma levels of benzoate and phenylacetate were excessively high. The possible mechanisms of toxicity, management and safety measures are discussed.

AB - Intravenous sodium benzoate and sodium phenylacetate have been used successfully in the treatment of acute hyperammonaemia in patients with urea cycle disorders. They provide alternative pathways for waste nitrogen disposal and help maintain nitrogen homeostasis. However, we report three patients with hyperammonaemia who received inappropriate doses of intravenous sodium benzoate and sodium phenylacetate that resulted in severe complications. Ambiguous medical prescriptions and inadequate cross-checking of drug dosage by physicians, nurses and pharmacists were the main causes of these incidents. All the patients presented with alteration in mental status, Kussmaul respiration and a partially compensated metabolic acidosis with an increased anion gap. Two patients developed cerebral oedema and hypotension and died. The third survived after haemodialysis. Plasma levels of benzoate and phenylacetate were excessively high. The possible mechanisms of toxicity, management and safety measures are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0034076850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034076850&partnerID=8YFLogxK

U2 - 10.1023/A:1005661631281

DO - 10.1023/A:1005661631281

M3 - Article

VL - 23

SP - 129

EP - 136

JO - Journal of Inherited Metabolic Disease

JF - Journal of Inherited Metabolic Disease

SN - 0141-8955

IS - 2

ER -